Germain Dominique P, Brand Eva, Burlina Alessandro, Cecchi Franco, Garman Scott C, Kempf Judy, Laney Dawn A, Linhart Aleš, Maródi László, Nicholls Kathy, Ortiz Alberto, Pieruzzi Federico, Shankar Suma P, Waldek Stephen, Wanner Christoph, Jovanovic Ana
Division of Medical Genetics, University of Versailles, Paris-Saclay University, Montigny, France.
Department of Nephrology, Hypertension and Rheumatology, University Hospital Münster, Münster, Germany.
Mol Genet Genomic Med. 2018 Apr 12;6(4):492-503. doi: 10.1002/mgg3.389.
The p.Asn215Ser or p.N215S GLA variant has been associated with late-onset cardiac variant of Fabry disease.
To expand on the scarce phenotype data, we analyzed natural history data from 125 p.N215S patients (66 females, 59 males) enrolled in the Fabry Registry (NCT00196742) and compared it with data from 401 patients (237 females, 164 males) harboring mutations associated with classic Fabry disease. We evaluated interventricular septum thickness (IVST), left ventricular posterior wall thickness (LVPWT), estimated glomerular filtration rate and severe clinical events.
In p.N215S males, mildly abnormal mean IVST and LVPWT values were observed in patients aged 25-34 years, and values gradually increased with advancing age. Mean values were similar to those of classic males. In p.N215S females, these abnormalities occurred primarily in patients aged 55-64 years. Severe clinical events in p.N215S patients were mainly cardiac (males 31%, females 8%) while renal and cerebrovascular events were rare. Renal impairment occurred in 17% of p.N215S males (mostly in patients aged 65-74 years), and rarely in females (3%).
p.N215S is a disease-causing mutation with severe clinical manifestations found primarily in the heart. Cardiac involvement may become as severe as in classic Fabry patients, especially in males.
p.Asn215Ser或p.N215S GLA变异与法布里病的迟发性心脏变异型相关。
为了扩充稀少的表型数据,我们分析了法布里注册研究(NCT00196742)中125例p.N215S患者(66例女性,59例男性)的自然病史数据,并将其与401例携带经典法布里病相关突变的患者(237例女性,164例男性)的数据进行比较。我们评估了室间隔厚度(IVST)、左心室后壁厚度(LVPWT)、估计肾小球滤过率和严重临床事件。
在p.N215S男性患者中,25 - 34岁患者的平均IVST和LVPWT值轻度异常,且这些值随年龄增长逐渐升高。平均值与经典型男性患者相似。在p.N215S女性患者中,这些异常主要发生在55 - 64岁的患者中。p.N215S患者的严重临床事件主要为心脏事件(男性31%,女性8%),而肾脏和脑血管事件较少见。17%的p.N215S男性患者出现肾功能损害(主要为65 - 74岁患者),女性患者中很少见(3%)。
p.N215S是一种致病突变,主要在心脏出现严重临床表现。心脏受累可能与经典法布里病患者一样严重,尤其是在男性患者中。